genetically modified regulatory T cells (Weizmann)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namegenetically modified regulatory T cells (Weizmann)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionT lymphocytes stimulantsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYeda Research and Development Co LtdWeizmann Institute Of Science
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A